Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
![]() |
DentsplyXRAY |
-$16,000 |
![]() |
Align TechnologyALGN |
-$9,000 |
![]() |
SterisSTE |
$16,000 |
![]() |
AngiodynamicANGO |
-$8,000 |
![]() |
HologicHOLX |
-$16,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Gilbert Cisneros | May 6, 2025 | Buy | $1K - $15K |
| Josh Gottheimer | Jul 19, 2024 | Buy | $1K - $15K |
| Josh Gottheimer | Jun 18, 2024 | Sell | $1K - $15K |
FAQ - Congress Trading
Gilbert Cisneros purchased Atricure shares most recently on May 6, 2025.
Josh Gottheimer has bought the most ATRC stock in the last 2 years, with an estimated value of $8,000.
Josh Gottheimer has sold the most ATRC stock in the last 2 years, with an estimated value of $8,000.
According to our estimates, the net value of trades by US politicians for Atricure in the last 2 years is positive, amounting to $8,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
Over the last 2 years, insider transactions for Atricure have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.




